{"id":5278,"date":"2026-07-23T13:47:43","date_gmt":"2026-07-23T11:47:43","guid":{"rendered":"https:\/\/docuply.io\/eqms-software-compared-2026\/"},"modified":"2026-07-23T13:59:20","modified_gmt":"2026-07-23T11:59:20","slug":"eqms-software-compared-2026","status":"publish","type":"page","link":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/","title":{"rendered":"eQMS Software Compared 2026: The Most Relevant Vendors for Biotechs from Phase I to Approval"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"5278\" class=\"elementor elementor-5278 elementor-5251\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5892923 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5892923\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7888e04\" data-id=\"7888e04\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-dc8d2bf elementor-widget elementor-widget-image\" data-id=\"dc8d2bf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1920\" height=\"500\" src=\"https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma.png\" class=\"attachment-full size-full wp-image-5257\" alt=\"\" srcset=\"https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma.png 1920w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-300x78.png 300w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-1024x267.png 1024w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-768x200.png 768w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-1536x400.png 1536w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-131x34.png 131w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-307x80.png 307w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-394x103.png 394w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-915x238.png 915w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-1240x323.png 1240w\" sizes=\"(max-width: 1920px) 100vw, 1920px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-c3d1a42 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"c3d1a42\" data-element_type=\"section\" data-e-type=\"section\" id=\"whitepaper-download\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-fef8d15\" data-id=\"fef8d15\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c163395 elementor-widget elementor-widget-text-editor\" data-id=\"c163395\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Last updated: July 7, 2026<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3d0bf04 elementor-widget elementor-widget-text-editor\" data-id=\"3d0bf04\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2>Intro<\/h2>\n<p>Biotech organisations searching for an electronic quality management system (eQMS) to carry them from the first clinical phase through to approval face a confusing vendor landscape. This comparison is written for quality, regulatory and clinical operations leaders at growing sponsors who need a GxP-compliant system for document control, training, deviations\/CAPAs, change control and the trial master file. Deliberately, this is not a complete market overview but a selection of the ten vendors most relevant to that audience. We assess eight criteria, including \u2013 for the first time \u2013 a precise AI-native rating based on a three-tier model that separates marketing claims from genuine automation that reaches into validated GxP processes. All vendor facts were researched via web search in July 2026; uncertain figures are flagged as &#8220;per the vendor&#8221; or with a date. Docuply, the publisher of this page, is held to the same honest standard as every other vendor, weaknesses included.<\/p>\n<h2>The three-tier model for AI-native rating<\/h2>\n<p><\/p>\n<ul>\n<li><strong>Tier 1 \u2013 Simple AI assistants:<\/strong> chatbots, Q&amp;A helpers and text suggestions that do not reach into validated GxP processes. Validation impact is low: usually deployable as a nice-to-have outside the scope of GxP records.<\/li>\n<li><strong>Tier 2 \u2013 Deeply integrated AI features:<\/strong> AI automates real steps within the validated process, for example generating training questionnaires, automatic change history, automatic filing of document versions, suggestions for linking documents into the eTMF, and CAPA suggestions. Validation impact is material: these functions create or alter GxP records and must be validated on a risk basis under GAMP 5 (Second Edition). The benefit is greatest for small teams, because precisely these steps absorb most of the manual QA time.<\/li>\n<li><strong>Tier 3 \u2013 AI agents:<\/strong> autonomous agent systems that carry out multi-step tasks on their own. They require particularly thorough assessment and validation: every decision path, every data source and every fallback route has to be documented, alongside continuous monitoring and revalidation whenever models change. For clinical biotechs this often means considerable additional effort for comparatively little benefit in practice, since typical workloads (a high number of SOPs but manageable CAPA volumes) do not call for autonomous multi-step automation. Agent systems also tend to carry ongoing token costs that scale with usage and make total costs hard to forecast.<\/li>\n<\/ul>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7b0d42c elementor-widget elementor-widget-text-editor\" data-id=\"7b0d42c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2>Comparison tables<\/h2><br><h3>Comparison table 1: compliance, validation and operation (as of July 2026)<\/h3><br><div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; margin: 1.5em 0;\">\r\n<table style=\"border-collapse: collapse; width: 100%; min-width: 760px; font-size: 15px; line-height: 1.5;\">\r\n<thead>\r\n<tr>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">Vendor<\/th>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">GxP compliance (Part 11\/Annex 11)<\/th>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">Validation effort<\/th>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">Implementation (weeks)<\/th>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">Hosting\/cloud-native<\/th>\r\n<\/tr>\r\n<\/thead>\r\n<tbody>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Docuply<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 + Annex 11<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low (IQ\/OQ included)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">approx. 1\u20133 (start in minutes)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">EU cloud (Germany), cloud-native<\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Veeva Vault QMS<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 + Annex 11<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">High<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">12\u201326 (Basics: 4\u20138)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">US parent, EU data centres, cloud-native<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>MasterControl<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 + Annex 11<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Medium\u2013high<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">12\u201326<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">US, cloud (also SaaS), cloud-native<\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Qualio<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 + Annex 11<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low (pre-validated)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">4\u20139<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">US (cloud), cloud-native<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>ZenQMS<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 + Annex 11<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low\u2013medium<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">4\u201313 (go-live 30\u201390 days)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">US (cloud), cloud-native<\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>SimplerQMS<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 + Annex 11<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low (pre-validated)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">5\u20136<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">AWS (EU selectable), cloud-native<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Greenlight Guru<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 + 820\/QMSR<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low (pre-validated)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">4\u201312<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">US (cloud), cloud-native<\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Dot Compliance<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 + Annex 11<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Medium<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">8\u201316<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">US\/Salesforce, cloud-native<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>TrackWise Digital<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 + Annex 11<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">High<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">12\u201326<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">US\/Salesforce+AWS, cloud-native<\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>QT9 QMS<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Yes, Part 11 (FDA\/ISO)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low\u2013medium<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">4\u20138 (&lt;30 days possible)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">US (cloud or on-prem)<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-db8dc1f elementor-widget elementor-widget-text-editor\" data-id=\"db8dc1f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h3>Comparison table 2: pricing, fit and AI-native tier (as of July 2026)<\/h3><br><div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; margin: 1.5em 0;\">\r\n<table style=\"border-collapse: collapse; width: 100%; min-width: 760px; font-size: 15px; line-height: 1.5;\">\r\n<thead>\r\n<tr>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">Vendor<\/th>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">Price transparency<\/th>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">Target size<\/th>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">UI\/UX<\/th>\r\n<th style=\"background: #f4f7fa; color: #1b3a5c; font-weight: bold; text-align: left; padding: 12px 14px; border: 1px solid #dde3ea; border-bottom: 2px solid #1b3a5c;\">AI-native tier<\/th>\r\n<\/tr>\r\n<\/thead>\r\n<tbody>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Docuply<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">High: \u20ac99\/user\/month (~\u00a384), free tier, AI included<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Up to ~150 staff, biotech\/pharma<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Very simple (deliberately lean)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 2<\/strong> (no token costs, fair use)<\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Veeva Vault QMS<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low (no list prices)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Mid-market to enterprise<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Solid, complex<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 2\u21923<\/strong> (agents from April 2026)<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>MasterControl<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low (from ~$25,000\/year)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">SMB to enterprise<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Feature-rich, at times complex<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 2<\/strong><\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Qualio<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Medium (from ~$25,000\/year per third parties)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Startups\/scale-ups, life sciences<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Very simple<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 1\u21922<\/strong><\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>ZenQMS<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Medium (no seat pricing)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Startup to enterprise<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Simple<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 1<\/strong><\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>SimplerQMS<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">High (from $17,500\/year, up to 15 users)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Life sciences SMEs<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Solid<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 1<\/strong><\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Greenlight Guru<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low (from ~$30,000\/year per third parties)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">MedTech focus<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Very simple<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 2<\/strong> (MedTech)<\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Dot Compliance<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Startups to enterprise<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Salesforce-based, learning curve<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 1<\/strong> (Dottie)<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>TrackWise Digital<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Low<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Mid-market to enterprise<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Improved, historically complex<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 2<\/strong><\/td>\r\n<\/tr>\r\n<tr style=\"background: #fafbfc;\">\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>QT9 QMS<\/strong><\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Medium (quote required)<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">SMB to mid-market<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\">Simple, somewhat dated<\/td>\r\n<td style=\"padding: 11px 14px; border: 1px solid #dde3ea; vertical-align: top;\"><strong>Tier 1<\/strong><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-838037b elementor-widget elementor-widget-text-editor\" data-id=\"838037b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h2>Vendor profiles<\/h2>\n<p><strong>Docuply.<\/strong> A young German vendor from Mannheim, specialised in biotechs from Phase I through III and beyond, and well-suited to organisations of up to roughly 150 employees. Strengths: transparent pricing (\u20ac99\/user\/month, plus a free eDMS tier for up to 8 users), EU cloud hosting, IQ\/OQ documentation at no extra charge, and set-up in minutes. Docuply is one of few vendors to reach a genuine Tier 2 AI-native rating: automatic generation of SOP training questions, automatic linking of verified document versions into the trial master file (CDISC TMF Reference Model), automatic filing of document versions, automatic change history, and AI CAPA suggestions within Quality Events; founder Jan Krikava publicly names Mistral AI (France) as the technology partner. Important for budgeting: all AI features are included in the price. There are no token or consumption charges, with usage limited only by a fair use policy. Weaknesses, stated honestly: (1) a focus on clinical rather than MedTech; (2) a deliberately simple UI with less configurability; (3) a young vendor with a shorter track record and fewer reference studies than established players. API integrations are still on the roadmap.<\/p>\n<p><strong>Veeva Vault QMS.<\/strong> The market leader for life sciences content, deeply integrated with eTMF, RIM and Safety. Strengths: comprehensive functionality, every release delivered in a validated environment, EU data centres available. For small biotechs there is the pre-configured Veeva Basics programme (go-live on &#8220;day 1&#8221;, 30\u201360 days to first users). Weaknesses: high cost (no public list prices; per-user figures often in the low thousands of dollars per year according to industry analyses) and lengthy full implementations (3\u20136 months per module, up to three years globally). AI: Veeva AI Agents were announced by press release on 14 October 2025 and, per Veeva, run on &#8220;large language models (LLMs) from Anthropic and Amazon, hosted on Amazon Bedrock&#8221;; the Quality agents are available with release 26R1 in April 2026 (including quality event summaries, investigation narrative generation, document translation and APQR drafts). Veeva is therefore moving from Tier 2 towards Tier 3 \u2013 with the validation burden and cost that implies.<\/p>\n<p><strong>MasterControl.<\/strong> An established eQMS vendor for GMP\/QSR manufacturers, used by more than 1,100 customers according to its own figures (&#8220;trusted by 1,100+ customers&#8221;, including 50 of the top pharma and medical device manufacturers). Strengths: robust document, training, CAPA and audit management, a &#8220;one-button&#8221; validation tool (VxT\/VoD), and what the organisation describes as an ISO 42001-certified &#8220;AI-first platform \u2026 Always human-driven&#8221;. Tier 2 AI in concrete terms: MasterControl Assist automatically generates multiple-choice training questions and change control summaries, and translates documents. Weaknesses: the UI is often described as unintuitive and the reporting as clunky; pricing is high (from ~$25,000\/year, often &gt;$100,000\/year according to third parties) and implementation runs to several months.<\/p>\n<p><strong>Qualio.<\/strong> A cloud-native eQMS for life sciences startups and scale-ups. Strengths: very easy to use, a pre-validated package (per the vendor, 99% of customers do not validate it themselves), and go-live often within 30\u201360 days. AI: text tools (Summarize, Improve Writing, Simplify, Convert Instructions) and AI training question generation \u2013 largely Tier 1, with a Tier 2 element in the automatic change summaries and training questions. In 2025 Qualio announced &#8220;Compliance Intelligence&#8221; with AI gap analysis and &#8220;AI agents that monitor regulations, execute quality workflows&#8221;; the actual autonomy, however, remains limited and human-in-the-loop. Weaknesses: users report a lack of depth in some modules (e.g. training\/design control), and change control that works one document at a time.<\/p>\n<p><strong>ZenQMS.<\/strong> A configurable eQMS with fair, seat-less pricing. Strengths: easy to use, strong support, go-live in 30\u201390 days, validated to GAMP 5 Category 4 with free validation materials. AI: so far only in places \u2013 an &#8220;AI Test Question Generator&#8221; for training and &#8220;AI-assisted filter creation&#8221; in document search; further AI capabilities are still planned, according to users. That makes it Tier 1 overall, with a single Tier 2 element in the training question generator. Weaknesses: limited configurability, no real-time document co-editing, and a supplier management module with room to grow.<\/p>\n<p><strong>SimplerQMS.<\/strong> A pre-validated, Microsoft 365-integrated eQMS for life sciences, hosted on AWS. Strengths: all-inclusive pricing (per simplerqms.com, &#8220;The minimum subscription price is USD 17,500 annually, which covers up to 15 users&#8221;), implementation in five to six weeks, and Microsoft Office integration. AI: to date primarily the Microsoft 365\/Copilot integration as an AI assistant \u2013 Tier 1. Weaknesses: an interface perceived as an add-on to Microsoft (the consultancy OpenRegulatory quotes an auditor: &#8220;its interface mostly looks like Windows 95&#8221;), and a minimum price that is relatively high for very small teams.<\/p>\n<p><strong>Greenlight Guru.<\/strong> An eQMS specialised in medical devices, used by &#8220;1,100+ medical device companies&#8221; according to its own website (the 1,000 milestone was reached in late 2022). Strengths: MedTech-native workflows (DHF, design controls, ISO 13485\/QMSR), pre-validated, implementation in weeks. AI: concrete Tier 2 features for MedTech \u2013 one-click generation of training questions, automatic change order summaries, verifiability checks and suggested traceability links, always with a human in the loop. Weaknesses for the audience considered here: a clear MedTech focus, less tailored to pharma\/clinical GMP; opaque pricing (from ~$30,000\/year according to third parties).<\/p>\n<p><strong>Dot Compliance.<\/strong> A Salesforce-native, pre-configured eQMS for life sciences. Strengths: rapidly deployable processes, full validation packages, and scalability through Salesforce. AI: &#8220;Dottie&#8221;, described by the vendor as the first AI assistant trained specifically on quality workflows \u2013 functionally a Q&amp;A\/guidance assistant, so Tier 1. Weaknesses: a Salesforce learning curve, at times complex set-up, and higher costs owing to the Salesforce foundation.<\/p>\n<p><strong>TrackWise Digital (Honeywell).<\/strong> An enterprise eQMS on Salesforce with AWS AI, evolved from the classic TrackWise. Strengths: very deep process coverage (complaints, deviations, NC, CAPA, change control, audit) and strong analytics. Tier 2 AI: TrackWise AI uses generative AI\/NLP\/ML for auto-categorisation (classifying and triaging quality events and complaints) and auto-summarisation (automatic event summaries); per the vendor, &#8220;All AI-assisted quality records require human approval&#8221;. Weaknesses: high validation and implementation effort, a historically complex UI, and a fit that leans towards larger organisations; QuickTrack addresses smaller firms.<\/p>\n<p><strong>QT9 QMS.<\/strong> An all-in-one eQMS with more than 25 modules and concurrent licensing. Strengths: fast implementation (&lt;30 days possible), pre-validated IQ\/OQ\/PQ, affordable for SMBs, cloud or on-premise. AI: users mention a helpful &#8220;AI tool&#8221;, but with no evidenced intervention in validated GxP steps \u2013 Tier 1. Weaknesses: a somewhat dated interface, search that leans towards exact matches, and opaque pricing (quote required).<\/p>\n<h2>How to choose<\/h2>\n<p><\/p>\n<ul>\n<li><strong>Biotech Phase I\u2013III through to approval:<\/strong> for lean sponsors with a clinical focus, cloud-native, pre-validated systems with fast go-live are decisive. Docuply, Qualio and ZenQMS offer the lowest barriers to entry here; those wanting to tie the eTMF closely to the QMS will find native approaches at Docuply (automatic TMF linking) and Veeva (Vault ecosystem). Tier 2 AI delivers the best effort-to-benefit ratio in this segment; Tier 3 agents rarely do.<\/li>\n<li><strong>Growing sponsor of up to roughly 150 employees:<\/strong> transparent pricing and low validation effort are what count. Docuply (\u20ac99\/user\/month including all AI features), Qualio, ZenQMS and SimplerQMS are all well-suited; Veeva Basics is an option if a later move into the full Vault ecosystem is planned.<\/li>\n<li><strong>Enterprise:<\/strong> for global multi-site requirements, complex change controls and high CAPA volumes, Veeva Vault QMS, MasterControl and TrackWise Digital lead the field \u2013 with commensurate validation and implementation effort. This is where Tier 3 agents are most likely to pay off, because the case volumes carry the validation burden.<\/li>\n<li><strong>MedTech:<\/strong> Greenlight Guru is the obvious choice here (ISO 13485, QMSR, DHF); Docuply is deliberately not MedTech-focused.<\/li>\n<\/ul>\n<p><\/p>\n<h2>AI automation vs validation risk<\/h2>\n<p>The decisive point with AI in an eQMS is not the marketing term but the extent to which it reaches into validated GxP processes. The three-tier model makes that measurable:<\/p>\n<p><strong>Tier 1<\/strong> (chatbots, Q&amp;A, text suggestions) generally creates no GxP records and can be used outside the validated core process. Validation effort stays low; often a risk assessment confirming that the function alters no record is enough. Examples: Dottie (Dot Compliance), the SimplerQMS Copilot, the QT9 AI tool.<\/p>\n<p><strong>Tier 2<\/strong> (automatic training questions, change history, document versioning, eTMF linking, CAPA suggestions) reaches directly into validated steps and creates or alters GxP records. Validation effort rises accordingly: under GAMP 5 (Second Edition, 2022, with Appendix D11 on AI\/ML) these functions must be validated on a risk basis, including evidence of data integrity (ALCOA+), test cases for the AI logic and documented human control. Docuply, Greenlight Guru, MasterControl and TrackWise Digital fall squarely into this tier. Crucially, an AI-generated training questionnaire or CAPA suggestion is a draft that a human must review and approve \u2013 the audit trail must capture that human accountability without gaps. For clinical sponsors this is, in practice, the point with the best ratio of time saved to validation effort: the additional evidence required is clearly bounded, whilst the QA time recovered is substantial.<\/p>\n<p><strong>Tier 3<\/strong> (autonomous AI agents) raises the requirements considerably. Autonomous agent systems demand particularly thorough assessment and validation: every decision path, every connected data source and every escalation or fallback route has to be documented, supplemented by continuous validation of dynamic SaaS systems (as required in the draft 2025 revision of EU Annex 11), immutable audit logs and an AI governance model with clear human roles. For clinical biotech organisations, that effort frequently buys little in return: with a few dozen SOPs, manageable deviation and CAPA volumes and a small QA team, autonomous multi-step automation is rarely the bottleneck. There is also the cost dimension: agent systems consume substantial model capacity and are therefore often billed by usage through tokens, which makes total costs hard to forecast. Veeva is the most prominent case here: the Veeva AI Agents announced on 14 October 2025 run on LLMs from Anthropic and Amazon (Amazon Bedrock); Quality agents have been available since April 2026 (release 26R1) and handle, for example, case intake support, medical coding, deviation triage and document summaries. The degree of autonomy remains deliberately bounded: Veeva confines the agents to known data sources, and human review is expected.<\/p>\n<p>Docuply is a special case when it comes to cost: all Tier 2 AI features are included in the subscription at no surcharge, no token or consumption charges arise, and usage is limited only by a fair use policy. For small sponsors that matters for planning, because usage-based AI pricing models otherwise become expensive precisely when the automation is actually being used intensively.<\/p>\n<p>The regulatory frame for all three tiers: the FDA&#8217;s CSA guidance (2025), GAMP 5 (Second Edition) with its AI\/ML appendix, the draft EU GMP Annex 22 on AI, and the ongoing Annex 11 revision. As a rule of thumb: the higher the AI tier, the greater the potential benefit \u2013 but also the higher the validation, governance and running costs. For most clinical biotechs, the optimum sits at Tier 2.<\/p>\n<h2>FAQ<\/h2>\n<p><strong>What does eQMS software cost?<\/strong><br \/>The range is wide. Mid-market systems typically run at around $2,000 per user per year according to industry figures, whilst enterprise contracts reach six-figure annual totals. Concrete anchors: Docuply at \u20ac99\/user\/month (set-up, onboarding, support and AI features included), SimplerQMS from $17,500\/year for up to 15 users, MasterControl from ~$25,000\/year (often &gt;$100,000), and Veeva with no list prices (per-user figures often several thousand dollars a year according to analyses). Watch for hidden costs in validation, implementation, onboarding and support \u2013 and, increasingly, for usage-based AI or token charges.<\/p>\n<p><strong>Do AI features in an eQMS cost extra?<\/strong><br \/>That depends on the vendor. Many charge for AI either through higher tariff tiers or by consumption through tokens, particularly for agentic capabilities. At Docuply all AI features are included in the subscription at no cost; no token charges arise, and usage is limited only by a fair use policy.<\/p>\n<p><strong>Is eQMS software 21 CFR Part 11 compliant?<\/strong><br \/>All ten vendors compared here support 21 CFR Part 11 and EU Annex 11 (electronic signatures, audit trails, access controls). Importantly, the vendor supplies the technical controls; compliant use and validation within your own process remain the customer&#8217;s responsibility.<\/p>\n<p><strong>US or EU hosting \u2013 what applies for GDPR?<\/strong><br \/>Storage location alone is not decisive. Under the US CLOUD Act (2018), US authorities can request data from US providers even when it is held in Frankfurt or Dublin \u2013 which sits in tension with Article 48 GDPR (Schrems II, 2020). For sensitive data, a vendor with no US corporate ties, or with EU-managed encryption, is advantageous. Docuply hosts exclusively in the EU; Veeva, MasterControl, Qualio, Greenlight Guru and TrackWise are US corporations (some with EU data centres); SimplerQMS uses AWS with a selectable EU region.<\/p>\n<p><strong>How long does an eQMS implementation take?<\/strong><br \/>Cloud-native, pre-validated systems such as Docuply, Qualio, QT9 or Greenlight Guru can be live in 4 weeks to a few months. Enterprise systems such as MasterControl or Veeva typically need 3\u20136 months per module, and global multi-site rollouts longer.<\/p>\n<p><strong>What does &#8220;AI-native&#8221; really mean for an eQMS?<\/strong><br \/>Not every chatbot is genuine automation. Tier 1 covers assistants that do not reach into GxP processes; Tier 2 automates real steps within the validated process (e.g. training questions, CAPA suggestions, eTMF linking); Tier 3 is autonomous agent systems. The higher the tier, the greater both the potential benefit and the validation effort.<\/p>\n<p><strong>Does AI functionality change the validation effort?<\/strong><br \/>Yes. Tier 1 functions are usually of low validation relevance. Tier 2 and Tier 3 functions reach into GxP records and must be validated on a risk basis under GAMP 5 (Second Edition), with documented human control and a complete audit trail. Tier 3 agents additionally require continuous monitoring and revalidation whenever models change.<\/p>\n<p><strong>Which eQMS suits a biotech ahead of its first approval?<\/strong><br \/>For lean, clinically focused sponsors of up to ~150 employees, Docuply, Qualio and ZenQMS are obvious candidates; for a tightly integrated eTMF-plus-QMS, Docuply or the Veeva Vault ecosystem.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-c1f2622 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"c1f2622\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-10a7989\" data-id=\"10a7989\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-4b53d93 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4b53d93\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-4ebf38e\" data-id=\"4ebf38e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6ebe06c elementor-widget elementor-widget-image\" data-id=\"6ebe06c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-150x150.jpg\" class=\"attachment-thumbnail size-thumbnail wp-image-5262\" alt=\"Jan Krikava\" srcset=\"https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-150x150.jpg 150w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-300x300.jpg 300w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-768x768.jpg 768w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-34x34.jpg 34w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-80x80.jpg 80w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-394x394.jpg 394w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-303x303.jpg 303w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-605x605.jpg 605w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-700x700.jpg 700w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px-950x950.jpg 950w, https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/2026-03-Avatar-10241024px.jpg 1024w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-1bc7840\" data-id=\"1bc7840\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2cf0047 elementor-widget elementor-widget-text-editor\" data-id=\"2cf0047\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Author: <\/strong>Jan Krikava \u2013 A former life science consultant who founded Docuply on the back of his own consulting experience. 14 years of experience in quality management. Business Informatics B. Sc. LinkedIn: <a href=\"https:\/\/www.linkedin.com\/in\/jan-krikava\" target=\"_blank\" rel=\"noopener\">linkedin.com\/in\/jan-krikava<\/a><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-689e877 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"689e877\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-78e20e0\" data-id=\"78e20e0\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-55272c8 elementor-widget elementor-widget-image\" data-id=\"55272c8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"800\" height=\"560\" src=\"https:\/\/docuply.io\/wp-content\/uploads\/2024\/08\/2024-07-Docuply-MB-Render-800px.png\" class=\"attachment-large size-large wp-image-4093\" alt=\"\" srcset=\"https:\/\/docuply.io\/wp-content\/uploads\/2024\/08\/2024-07-Docuply-MB-Render-800px.png 800w, https:\/\/docuply.io\/wp-content\/uploads\/2024\/08\/2024-07-Docuply-MB-Render-800px-300x210.png 300w, https:\/\/docuply.io\/wp-content\/uploads\/2024\/08\/2024-07-Docuply-MB-Render-800px-768x538.png 768w, https:\/\/docuply.io\/wp-content\/uploads\/2024\/08\/2024-07-Docuply-MB-Render-800px-49x34.png 49w, https:\/\/docuply.io\/wp-content\/uploads\/2024\/08\/2024-07-Docuply-MB-Render-800px-114x80.png 114w, https:\/\/docuply.io\/wp-content\/uploads\/2024\/08\/2024-07-Docuply-MB-Render-800px-394x276.png 394w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-5d580ee\" data-id=\"5d580ee\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0c4ae00 elementor-widget elementor-widget-heading\" data-id=\"0c4ae00\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">Docuply: The AI-native eQMS with a fully integrated eTMF for clinical biotech start-ups, pre-validated and ready for immediate use.<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6f6ffe7 elementor-invisible elementor-widget elementor-widget-button\" data-id=\"6f6ffe7\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;slideInUp&quot;}\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-lg\" href=\"https:\/\/docuply.io\/en\/demo\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Book your demo<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Last updated: July 7, 2026 Intro Biotech organisations searching for an electronic quality management system (eQMS) to carry them from the first clinical phase through to approval face a confusing vendor landscape. This comparison is written for quality, regulatory and &hellip; <a href=\"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/\">Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":5284,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5278","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>eQMS Software Compared 2026: The Most Relevant Vendors for Biotechs from Phase I to Approval | Docuply<\/title>\n<meta name=\"description\" content=\"Biotech organisations searching for an electronic quality management system (eQMS) to carry them from first-in-human through (...)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"eQMS Software Compared 2026: The Most Relevant Vendors for Biotechs from Phase I to Approval | Docuply\" \/>\n<meta property=\"og:description\" content=\"Biotech organisations searching for an electronic quality management system (eQMS) to carry them from first-in-human through (...)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Docuply\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T11:59:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/docuply.io\/wp-content\/uploads\/2023\/01\/Herausforderungen-bei-der-Zusammenarbeit-mit-CROs-CMOs-und-CDMOs-1024x576.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/docuply.io\/wp-content\/uploads\/2023\/01\/Herausforderungen-bei-der-Zusammenarbeit-mit-CROs-CMOs-und-CDMOs-1024x576.jpg\" \/>\n<meta name=\"twitter:site\" content=\"@docuplyio\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"15 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/eqms-software-compared-2026\\\/\",\"url\":\"https:\\\/\\\/docuply.io\\\/en\\\/eqms-software-compared-2026\\\/\",\"name\":\"eQMS Software Compared 2026: The Most Relevant Vendors for Biotechs from Phase I to Approval | Docuply\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/eqms-software-compared-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/eqms-software-compared-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-2048px.png\",\"datePublished\":\"2026-07-23T11:47:43+00:00\",\"dateModified\":\"2026-07-23T11:59:20+00:00\",\"description\":\"Biotech organisations searching for an electronic quality management system (eQMS) to carry them from first-in-human through (...)\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/eqms-software-compared-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/docuply.io\\\/en\\\/eqms-software-compared-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/eqms-software-compared-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-2048px.png\",\"contentUrl\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-2048px.png\",\"width\":2048,\"height\":2048},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/eqms-software-compared-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/docuply.io\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"eQMS Software Compared 2026: The Most Relevant Vendors for Biotechs from Phase I to Approval\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/docuply.io\\\/en\\\/\",\"name\":\"Docuply\",\"description\":\"Das elektronische Qualit\u00e4ts\u00admanagement\u00adsystem f\u00fcr Pharma-\u00adKMU und Biotech Start-Ups\",\"publisher\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/docuply.io\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#organization\",\"name\":\"Docuply\",\"url\":\"https:\\\/\\\/docuply.io\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Docuply-Logo-1.0.svg\",\"contentUrl\":\"https:\\\/\\\/docuply.io\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/Docuply-Logo-1.0.svg\",\"width\":2913,\"height\":719,\"caption\":\"Docuply\"},\"image\":{\"@id\":\"https:\\\/\\\/docuply.io\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/docuplyio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/docuply\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"eQMS Software Compared 2026: The Most Relevant Vendors for Biotechs from Phase I to Approval | Docuply","description":"Biotech organisations searching for an electronic quality management system (eQMS) to carry them from first-in-human through (...)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/","og_locale":"en_US","og_type":"article","og_title":"eQMS Software Compared 2026: The Most Relevant Vendors for Biotechs from Phase I to Approval | Docuply","og_description":"Biotech organisations searching for an electronic quality management system (eQMS) to carry them from first-in-human through (...)","og_url":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/","og_site_name":"Docuply","article_modified_time":"2026-07-23T11:59:20+00:00","og_image":[{"url":"https:\/\/docuply.io\/wp-content\/uploads\/2023\/01\/Herausforderungen-bei-der-Zusammenarbeit-mit-CROs-CMOs-und-CDMOs-1024x576.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_image":"https:\/\/docuply.io\/wp-content\/uploads\/2023\/01\/Herausforderungen-bei-der-Zusammenarbeit-mit-CROs-CMOs-und-CDMOs-1024x576.jpg","twitter_site":"@docuplyio","twitter_misc":{"Est. reading time":"15 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/","url":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/","name":"eQMS Software Compared 2026: The Most Relevant Vendors for Biotechs from Phase I to Approval | Docuply","isPartOf":{"@id":"https:\/\/docuply.io\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/#primaryimage"},"image":{"@id":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-2048px.png","datePublished":"2026-07-23T11:47:43+00:00","dateModified":"2026-07-23T11:59:20+00:00","description":"Biotech organisations searching for an electronic quality management system (eQMS) to carry them from first-in-human through (...)","breadcrumb":{"@id":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/docuply.io\/en\/eqms-software-compared-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/#primaryimage","url":"https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-2048px.png","contentUrl":"https:\/\/docuply.io\/wp-content\/uploads\/2026\/07\/eQMS-Comparison-2026-Electronic-Quality-Management-Systems-Biotech-Pharma-2048px.png","width":2048,"height":2048},{"@type":"BreadcrumbList","@id":"https:\/\/docuply.io\/en\/eqms-software-compared-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/docuply.io\/en\/"},{"@type":"ListItem","position":2,"name":"eQMS Software Compared 2026: The Most Relevant Vendors for Biotechs from Phase I to Approval"}]},{"@type":"WebSite","@id":"https:\/\/docuply.io\/en\/#website","url":"https:\/\/docuply.io\/en\/","name":"Docuply","description":"Das elektronische Qualit\u00e4ts\u00admanagement\u00adsystem f\u00fcr Pharma-\u00adKMU und Biotech Start-Ups","publisher":{"@id":"https:\/\/docuply.io\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/docuply.io\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/docuply.io\/en\/#organization","name":"Docuply","url":"https:\/\/docuply.io\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/docuply.io\/en\/#\/schema\/logo\/image\/","url":"https:\/\/docuply.io\/wp-content\/uploads\/2021\/12\/Docuply-Logo-1.0.svg","contentUrl":"https:\/\/docuply.io\/wp-content\/uploads\/2021\/12\/Docuply-Logo-1.0.svg","width":2913,"height":719,"caption":"Docuply"},"image":{"@id":"https:\/\/docuply.io\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/docuplyio","https:\/\/www.linkedin.com\/company\/docuply\/"]}]}},"_links":{"self":[{"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/pages\/5278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/comments?post=5278"}],"version-history":[{"count":1,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/pages\/5278\/revisions"}],"predecessor-version":[{"id":5279,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/pages\/5278\/revisions\/5279"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/media\/5284"}],"wp:attachment":[{"href":"https:\/\/docuply.io\/en\/wp-json\/wp\/v2\/media?parent=5278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}